Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer

Kyeara N. Mack; Zachary V. Samuels; Lukas M. Carter; Tara D. Viray; Komal Mandleywala; Cory L. Brooks; Michael A. Hollingsworth; Prakash Radhakrishnan; Jason S. Lewis

doi:10.2967/jnumed.123.266524

Research ArticleFEATURED BASIC SCIENCE ARTICLE

Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer

Kyeara N. Mack, Zachary V. Samuels, Lukas M. Carter, Tara D. Viray, Komal Mandleywala, Cory L. Brooks, Michael A. Hollingsworth, Prakash Radhakrishnan and Jason S. Lewis

Journal of Nuclear Medicine April 2024, 65 (4) 580-585; DOI: https://doi.org/10.2967/jnumed.123.266524

Kyeara N. Mack

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

2Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zachary V. Samuels

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lukas M. Carter

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tara D. Viray

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Komal Mandleywala

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cory L. Brooks

3Department of Chemistry and Biochemistry, California State University, Fresno, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael A. Hollingsworth

4Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Prakash Radhakrishnan

4Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jason S. Lewis

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

2Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York;

5Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue 4

April 1, 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer

Kyeara N. Mack, Zachary V. Samuels, Lukas M. Carter, Tara D. Viray, Komal Mandleywala, Cory L. Brooks, Michael A. Hollingsworth, Prakash Radhakrishnan, Jason S. Lewis

Journal of Nuclear Medicine Apr 2024, 65 (4) 580-585; DOI: 10.2967/jnumed.123.266524

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer

Kyeara N. Mack, Zachary V. Samuels, Lukas M. Carter, Tara D. Viray, Komal Mandleywala, Cory L. Brooks, Michael A. Hollingsworth, Prakash Radhakrishnan, Jason S. Lewis

Journal of Nuclear Medicine Apr 2024, 65 (4) 580-585; DOI: 10.2967/jnumed.123.266524

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

PET imaging
radioimmunotherapy
MUC16
huAR9.6
ovarian cancer

Main menu

User menu

Search

Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords